Satsuma Pharmaceuticals Performance
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Satsuma Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Satsuma Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Satsuma Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 15.8 M |
Satsuma |
Satsuma Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest (100.00) in Satsuma Pharmaceuticals on December 17, 2024 and sell it today you would earn a total of 100.00 from holding Satsuma Pharmaceuticals or generate -100.0% return on investment over 90 days. Satsuma Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Satsuma, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Satsuma Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Satsuma Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Satsuma Pharmaceuticals, and traders can use it to determine the average amount a Satsuma Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| STSA |
Based on monthly moving average Satsuma Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Satsuma Pharmaceuticals by adding Satsuma Pharmaceuticals to a well-diversified portfolio.
Satsuma Pharmaceuticals Fundamentals Growth
Satsuma Stock prices reflect investors' perceptions of the future prospects and financial health of Satsuma Pharmaceuticals, and Satsuma Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Satsuma Stock performance.
| Return On Equity | -1.04 | |||
| Return On Asset | -0.5 | |||
| Current Valuation | (35.53 M) | |||
| Shares Outstanding | 33.15 M | |||
| Price To Earning | 22.12 X | |||
| Price To Book | 0.42 X | |||
| EBITDA | (58.31 M) | |||
| Cash And Equivalents | 68.06 M | |||
| Cash Per Share | 2.15 X | |||
| Total Debt | 205 K | |||
| Debt To Equity | 0 % | |||
| Book Value Per Share | 1.14 X | |||
| Cash Flow From Operations | (51.52 M) | |||
| Earnings Per Share | (1.99) X | |||
| Total Asset | 54.94 M | |||
| Retained Earnings | (211.79 M) | |||
Things to note about Satsuma Pharmaceuticals performance evaluation
Checking the ongoing alerts about Satsuma Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Satsuma Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Satsuma Pharmaceuticals is not yet fully synchronised with the market data | |
| Satsuma Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Satsuma Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (70.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Satsuma Pharmaceuticals currently holds about 68.06 M in cash with (51.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.15. | |
| Roughly 58.0% of the company shares are owned by institutional investors |
- Analyzing Satsuma Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Satsuma Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Satsuma Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Satsuma Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Satsuma Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Satsuma Pharmaceuticals' stock. These opinions can provide insight into Satsuma Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Satsuma Stock
If you are still planning to invest in Satsuma Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Satsuma Pharmaceuticals' history and understand the potential risks before investing.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |